People · Operator
Named in public records as an officer, director or promoter · active 2011–2022 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Peptilogics, Inc. | — | Biotechnology | Series B | $40.9M | $1.2B | 2016 |
| Remesh Inc. | — | Other Technology | Series A | $26.7M | $43.6M | 2021 |
| Neolane SA | — | Other Technology | Series A | $13.0M | $360.6M | 2011 |
| Ariel Precision Medicine, Inc. | — | Biotechnology | Series A | $5.4M | $190.5M | 2016 |
Stephan Dietrich at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephan Dietrich on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Smith | 1 | 42 |
| Michael Brown | 1 | 34 |
| John Moore | 1 | 12 |
| Adam Valkin | 1 | 7 |
| Jason Camm | 1 | 5 |
| Dietrich Stephan | 1 | 4 |
| Catherine Mott | 1 | 4 |
| Mary Del Brady | 1 | 4 |
| Eric Schnadig | 1 | 3 |
| Steven Adler | 1 | 3 |
| Stefan Roever | 1 | 2 |
| Yuval Ariav | 1 | 2 |
| Nicolas Rose | 1 | 2 |
| Keith Price | 1 | 2 |
| Hank Safferstein | 1 | 2 |
| Christopher T.B. Moehle | 1 | 1 |
| David T.B. Smith | 1 | 1 |
| John T.B. Moore | 1 | 1 |
| Stephane Dehoche | 1 | 1 |
| Gilles Queru | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.